1. Home >
  2. Companies >
  3. Private >
  4. Life Science >
  5. United States >
  6. Washington >
  7. RareCyte

RareCyte Overview

Life ScienceCompany

Was RareCyte formerly PE-backed?

Yes. RareCyte was formerly owned by 1 private investor.

Where is RareCyte headquartered?

RareCyte is headquartered in Seattle, Washington.

What sector is RareCyte in?

RareCyte is a life science company.

When was RareCyte founded?

RareCyte was founded in 2009.

RareCyte

RareCyte, Inc.

2601 Fourth Avenue,
Seattle, Washington 98121
United States,
(855) 727-3298
www.rarecyte.com

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. RareCyte is dedicated to bringing its innovative technology to Life Sciences research, drug development, and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. RareCyte was founded in 2009 and is based in Seattle, Washington.


Company Summary

SECTOR

Life Science

Established

2009


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for RareCyte

Washington Companies , Life Science Companies , United States Companies , Washington Life Science Companies , Washington Life Science with Acquisitions , Washington Life Science with Divestitures

Related Lists for Washington Companies

Largest Washington Companies , Acquisitive Washington Companies , Recently Acquired Washington Companies , Recently Sold Washington Companies , Private Washington Companies , Public Washington Companies , Acquired Washington Companies , PE Backed Washington Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Solution for

Product

Company

Legal